Tomita, Naruya <br/><br/>
Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.  [electronic resource] 

 -  International journal of molecular medicine  May 2004 
 - 629-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1107-3756 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CDC2-CDC28 Kinases--genetics<br/>Cell Cycle--drug effects<br/>Cell Cycle Proteins--antagonists & inhibitors<br/>Cell Nucleus--metabolism<br/>Cyclin-Dependent Kinase 2<br/>DNA--administration & dosage<br/>DNA-Binding Proteins--antagonists & inhibitors<br/>Disease Models, Animal<br/>Drug Carriers--administration & dosage<br/>E2F Transcription Factors<br/>Gene Expression Regulation<br/>Genetic Therapy--methods<br/>Glomerulonephritis--chemically induced<br/>Isoantibodies--immunology<br/>Kidney--cytology<br/>Liposomes--administration & dosage<br/>Oligonucleotides--administration & dosage<br/>Proliferating Cell Nuclear Antigen--genetics<br/>RNA, Messenger--genetics<br/>Rats<br/>Sendai virus--genetics<br/>Transcription Factors--antagonists & inhibitors